Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
Pediatric Pulmonology|July 10, 2008
Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005Donald R VanDevanter, Lawrence Rasouliyan, Thomas M Murphy, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 13, 2024
Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiativeJonathan D Cogen, Sonya L Heltshe, Adam W Brothers, et al.Pediatric Pulmonology|June 19, 2015
Decline in lung function does not predict future decline in lung function in cystic fibrosis patientsMargaret Rosenfeld, Donald R VanDevanter, Clement L Ren, et al.Pediatric Pulmonology|August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosisJeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.Annals of the American Thoracic Society|January 10, 2018
Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic FibrosisMichael W Konstan, Donald R VanDevanter, Gregory S Sawicki, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2026
Density fluctuations of Burkholderia and Achromobacter in cystic fibrosis sputumLisa A Carmody, Lindsay J Caverly, Linda M Kalikin, et al.Contemporary Clinical Trials|November 25, 2017
Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CFSonya L Heltshe, Natalie E West, Donald R VanDevanter, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2024
Daily variability of Pseudomonas aeruginosa density in cystic fibrosis sputumLisa A Carmody, Lindsay J Caverly, Linda M Kalikin, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 6, 2022
Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosisLisa A Carmody, Linda M Kalikin, Donald R VanDevanter, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 15, 2015
Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosisJames F Chmiel, Michael W Konstan, Frank J Accurso, et al.Pageof 8